Int J Impot Res. 2018;30:262-269.
Hypogonadism therapy and fertility outcomes
Hill ED, Honig SC, Tabb KE, et al.
PreclinicalResearch compound
HMG (Fertility)
Human Menopausal Gonadotropin – 1:1 FSH+LH glycoprotein. Full spermatogenesis induction (dual Leydig + Sertoli axis), IVF superovulation. Clinical Rx for infertility indications (male HypoH + female IVF ovulation induction), NOT doping. Cross-frame: AAS-PCT context covered by the `hmg-perf` entry.
Available at
DRIADA-10% coupon: MOLEKULAX
DEUSPOWERProduct page
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Related comparisons
HMG (performance) vs HMG (peptides)WHAT IS HMG (FERTILITY)?
Detailed overview
HMG (Human Menopausal Gonadotropin) is a glycoprotein mixture purified from postmenopausal female urine, containing approximately 75 IU FSH (follicle-stimulating hormone) + 75 IU LH (luteinizing hormone) in 1:1 ratio per standard ampoule. Modern clinical HMG sources: (1) urinary-extracted (Menopur Ferring 2002 EMA, 2005 FDA – higher-purity urinary-purified product; the older Pergonal Serono 1962 was globally withdrawn ~2005 due to vCJD risk mitigation); (2) recombinant menotropin (research stage, limited clinical distribution). Dual gonadotropin-axis stimulus mechanism: HMG's unique value in clinical fertility treatment is that it stimulates BOTH Leydig cells (LH component → testosterone production) AND Sertoli cells (FSH component → spermatogenesis support + inhibin-B production). HCG monotherapy ONLY activates the Leydig-LH axis (intratesticular testosterone rises, but Sertoli-FSH support is absent) → full spermatogenesis induction requires combined HCG + HMG in hypogonadotropic hypogonadism (HypoH). Clinical indications (FDA + EMA Rx): (1) male spermatogenesis induction in HypoH (Kallmann syndrome, idiopathic HypoH, pituitary-origin infertility): 75-150 IU SC 3x/week × 6-24 months, stacked with HCG; (2) female IVF superovulation and COS (controlled ovarian stimulation): 75-300 IU/day individualized. Cross-frame note: same Menopur vial as in AAS-user PCT protocols (`hmg-perf` entry) – different narrative (clinical infertility vs sport-cycle recovery), IDENTICAL pharmacology. WADA-banned year-round (S2 Peptide Hormones).
Mechanism
1:1 FSH+LH glycoprotein mixture – Sertoli-FSHR + Leydig-LHCGR receptor double-stimulus, full HPG axis induction
Dosing (male HypoH spermatogenesis)
75-150 IU SC 3x/week × 6-24 months (stacked with HCG)
Dosing (female IVF/COS)
75-300 IU/day (individualized follicle-monitoring-based titration)
Half-life
FSH component ~12-20 h / LH component ~8-12 h
Legal status
FDA + EMA Rx Menopur (Ferring), WADA S2 (banned in+out-of-competition)
Growth hormone release
The peptide acts on pituitary GHRH or GHS receptors, producing a physiological, pulsatile GH release, unlike synthetic rHGH, which keeps levels flat and leads to desensitization. IGF-1 rises into the upper-normal range, driving recovery, muscle protein synthesis, lipolysis and skin quality. Deep-sleep phases lengthen; collagen and bone-matrix synthesis activate. The effect is reversible and does not suppress the endogenous GH axis.
Data console
Lab data
/lab/molecular-data.jsonLIVE
> Classification-
> StructureN/A
> Molecular weightN/A
> Target area-
> Storage2–8°C
> Stability~30 days reconstituted
Research indications
Investigated uses and mechanisms
Growth FactorsFertility / HPTA Support
Growth hormone release
Mimics physiological pulsatile GH secretion; IGF-1 rise.
Recovery & body comp
Muscle mass gain, fat reduction, post-workout recovery.
Sleep quality
Deep-sleep (N3) phases lengthen.
Quality indicators
How to recognize a pure peptide
Purity markers
4White / off-white powder
Typical appearance of sterile lyophilized peptide.
Comes with COA (Certificate of Analysis)
Independent lab analysis, ≥98% purity.
Intact, sealed vial
Rubber stopper + aluminum crimp intact, ensuring sterility.
Dissolves clear
Clear solution after reconstitution, no sediment.
Use caution
1Storage temperature
Extended room-temp exposure may reduce potency.
Do not use
2Discoloration / sediment
Yellow, cloudy or particulate solution, indicates degradation, do not use.
Damaged packaging
Cracked vial or loose cap, sterility compromised, discard.
Interactions & stacks
What to combine and what to avoid
HCG (fertilitás)
SynergisticLH-receptor agonist glycoprotein: fertility induction and HPTA recovery
CJC-1295
SynergisticGHRH analog: sustained growth hormone stimulation
Ipamorelin
SynergisticGHRH + GHRP, classic pulsatile GH stack.
Vitamin C / Zinc / B-complex
SynergisticSupports collagen synthesis and antioxidant capacity.
Caffeine
Requires timingCompatible with morning dosing; avoid late-day stacking.
Insulin
Use cautionContinuous glucose monitoring required.
NSAIDs (Ibuprofen, ASA)
Use cautionLong-term concurrent use may blunt regenerative effects.
Alcohol
AvoidReduces recovery and increases side-effect risk.
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Injection-site redness, itching
- Water retention, mild edema
- Wrist / joint stiffness (carpal-tunnel-like)
- Transient blood-glucose increase
- Mild prolactin / cortisol increase (some peptides)
Contraindications · 5
- Pregnancy and breastfeeding
- Active malignancy
- Known allergy to the peptide or its components
- Severe hepatic or renal impairment (medical consultation required)
- Age under 18
Related Peptides
Same therapeutic category
Studies
Related research and clinical findings
J Clin Endocrinol Metab. 2009;94(3):801-808.
Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome
Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ.
PMID: 19066302Open
Hum Reprod. 2002;17(3):625-633.
Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men
Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ.
PMID: 11870114Open
Telegram
Have a question about HMG (Fertility)?
Reach out to an advisor on Telegram. We can help you find the right peptide.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 2, 2026
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.